Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Ozempic Diarrhea Severity Grading: A Clinical Rubric for Semaglutide-Related GI Side Effects

By
Published Updated Last reviewed
2 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Diarrhea at 0.5 mg weekly / 8.5% vs 1.9% on placebo [1]
  • Diarrhea at 1 mg weekly / 8.8% vs 1.9% on placebo [1]
  • Severe GI reactions / 0% placebo, 0.4% at 0.5 mg, 0.8% at 1 mg [1]
  • Stopped for a GI reaction / 0.4% placebo, 3.1% at 0.5 mg, 3.8% at 1 mg [1]
  • Timing of most reports / during dose escalation [1]
  • 2 mg vs 1 mg, 40 weeks / any GI reaction 34% vs 30.8% [1]
  • Reactions at 5% or more in a dose group / nausea, vomiting, diarrhea, abdominal pain, constipation [1]
  • Kidney warning / acute kidney injury, mostly after GI fluid loss [1]

What the Ozempic label reports for diarrhea

The pooled placebo-controlled trials behind the Ozempic label included 262 people on placebo, 260 on 0.5 mg weekly and 261 on 1 mg weekly, with a mean exposure of 32.9 weeks [1]. Diarrhea was reported by 1.9% on placebo, 8.5% on 0.5 mg and 8.8% on 1 mg [1].

Diarrhea was not the most frequent GI complaint. Nausea was more common at both doses (15.8% and 20.3% versus 6.1% on placebo), while vomiting (5% and 9.2% versus 2.3%), abdominal pain (7.3% and 5.7% versus 4.6%) and constipation (5% and 3.1% versus 1.5%) fell in a similar range to diarrhea [1].

Gastrointestinal reactions of any kind were reported by 15.3% on placebo, 32.7% on 0.5 mg and 36.4% on 1 mg, and 0.4%, 3.1% and 3.8% respectively stopped treatment because of one [1]. Severe gastrointestinal reactions were reported in 0% on placebo, 0.4% on 0.5 mg and 0.8% on 1 mg [1]. That severe figure counts GI reactions of every kind, not diarrhea alone, so it is not a rate for severe diarrhea [1].

These are Ozempic figures in adults with type 2 diabetes. Wegovy is a separate FDA-approved product with its own trials and label, so its rates are not these [2].

Does severity rise with dose?

Diarrhea frequency was close at 0.5 mg and 1 mg (8.5% versus 8.8%), but severe GI reactions were numerically higher at 1 mg (0.8% versus 0.4%), as was GI-related discontinuation (3.8% versus 3.1%) [1].

The label's own 2 mg comparison comes from a 40-week trial of 959 adults: GI reactions occurred in 34% on 2 mg and 30.8% on 1 mg, and no new safety signals were identified [1].

The label states that the majority of reports of nausea, vomiting and diarrhea occurred during dose escalation. Titration runs 0.25 mg weekly for 4 weeks, then 0.5 mg, then 1 mg after at least 4 weeks on 0.5 mg, then 2 mg after at least 4 weeks on 1 mg [1].

What the severe end of the range looks like

The label's kidney warning describes acute kidney injury from volume depletion. It notes that most reported cases followed GI reactions causing dehydration such as nausea, vomiting or diarrhea, and says to monitor renal function in patients reporting reactions that could lead to volume depletion, especially during initiation and dose escalation [1].

The label's severe gastrointestinal adverse reactions warning says Ozempic has been associated with GI adverse reactions, sometimes severe, and that it is not recommended in patients with severe gastroparesis [1].

Abdominal pain is a different signal from loose stools. The label describes the pain of acute pancreatitis as persistent or severe, sometimes radiating to the back, with or without nausea or vomiting, and says to discontinue Ozempic if pancreatitis is suspected [1].

Is there a severity grade for Ozempic diarrhea?

No. The Ozempic label has no diarrhea-specific severity grade, and the trial figures above count GI reactions as a group. What the label singles out as serious is fluid loss that leads to kidney injury, and persistent or severe abdominal pain as a possible sign of pancreatitis [1].

Frequently asked questions

How common is diarrhea on Ozempic?
In the label's pooled placebo-controlled trials, diarrhea was reported by 8.5% of adults on 0.5 mg weekly and 8.8% on 1 mg, compared with 1.9% on placebo [1].
How does diarrhea compare with nausea on Ozempic?
Diarrhea was reported by 8.5% at 0.5 mg and 8.8% at 1 mg, while nausea was more common at 15.8% and 20.3%; placebo rates were 1.9% for diarrhea and 6.1% for nausea [1].
Is diarrhea worse at higher Ozempic doses?
Diarrhea frequency was nearly identical at 0.5 mg and 1 mg (8.5% and 8.8%), while severe GI reactions were 0.4% and 0.8% and GI-related discontinuation 3.1% and 3.8% [1]. In a 40-week trial of 959 adults, GI reactions occurred in 34% on 2 mg versus 30.8% on 1 mg [1].
When during treatment does Ozempic diarrhea appear?
The label says the majority of reports of nausea, vomiting and diarrhea occurred during dose escalation, when the dose steps from 0.25 mg to 0.5 mg, then 1 mg and 2 mg at intervals of at least 4 weeks [1].
What serious problems can diarrhea cause on Ozempic?
The label warns about acute kidney injury from volume depletion, noting that most reported cases followed GI reactions that caused dehydration such as nausea, vomiting or diarrhea, and directs monitoring of renal function during initiation and dose escalation [1].
How many people stop Ozempic because of GI side effects?
In the pooled placebo-controlled trials, 3.1% on 0.5 mg and 3.8% on 1 mg stopped treatment for a GI reaction, versus 0.4% on placebo [1].

References

  1. U.S. National Library of Medicine, DailyMed. Ozempic injection (Novo Nordisk) prescribing information. Ozempic injection (Novo Nordisk) label
  2. Drugs@FDA: FDA-Approved Drugs. Drugs@FDA: FDA-Approved Drugs
Evidence overview for Ozempic Diarrhea Severity Grading: A Clinical Rubric for Semaglutide-Related GI Side Effects